Loading...
Last update:
May 26, 2023
08:28 +1GMT
General Information
No Natural form
CHO
ReTiME
References
Hom s/Mus m Omalizumab
Homo sapiens
Continent
Test
Subjects
Positive
%
Europe
All
Basophil/Mast Cell Degranulation/Activation Test
Bronchial Challenge
Conjunctival Challenge
IgA
IgA Immunoblotting
IgA Multiplex
IgA1
IgA1 Immunoblotting
IgA1 Multiplex
IgA2
IgA2 Immunoblotting
IgA2 Multiplex
IgD
IgD Immunoblotting
IgD Multiplex
IgE
IgE Immunoblotting
IgE Multiplex
IgG
IgG Immunoblotting
IgG Multiplex
IgG1
IgG1 Immunoblotting
IgG1 Multiplex
IgG2
IgG2 Immunoblotting
IgG2 Multiplex
IgG3
IgG3 Immunoblotting
IgG3 Multiplex
IgG4
IgG4 Immunoblotting
IgG4 Multiplex
IgM
IgM Immunoblotting
IgM Multiplex
Injection Challenge Test
Intradermal Test - Classes
Intradermal Test - sqmm
Nasal Challenge
Oral Challenge, DBPC
Oral Challenge, Open
Patch Test
Photo Patch Test
Skin Test - Classes
Skin Test - sqmm
1,648
1,637
99.33
Country
Test
Subjects
Positive
%
Austria
all
35
33
94.29
Belgium
all
1
1
100.00
Bulgaria
all
1
1
100.00
Croatia
all
15
15
100.00
Germany
all
12
12
100.00
Hungary
all
26
26
100.00
Italy
all
1,468
1,460
99.46
Poland
all
35
34
97.14
Romania
all
15
15
100.00
Spain
all
19
19
100.00
Sweden
all
16
16
100.00
Switzerland
all
1
1
100.00
Ukraine
all
1
1
100.00
United Kingdom
all
3
3
100.00
Last update of the ReTiME database:
September 30, 2018 01:32 +1GMT
Allergome 2003-2015
Developed by
Panservice